| 产品描述: | TNF-α 选择性抑制剂 | 活化剂 | 拮抗剂;TNF-α Selective Inhibitors | Activators | Antagonists;;InformationCPI-1189 (REN 1654, REN 1189) is theproapoptotic cytokine tumor necrosis factor (TNF) alphainhibitor. CPI-1189 intracellularly inhibits the p38 mitogen-activated protein kinase phosphoactivation and shows neuroprotective effects.TargetsTNF-alpha |
| 体内研究: |
CPI-1189 (20 mg/kg, 口服一天两次) 可逆转 TNF-α 诱导的艾滋病痴呆大鼠模型的记忆缺陷 。 |
| 参考文献: |
1. Müller T. CPI-1189. Centaur. Curr Opin Investig Drugs. 2002 Dec;3(12):1763-7. 2. Clifford DB, et al. A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology. 2002 Nov 26;59(10):1568-73. 3. Li YJ, et al. CPI-1189 protects neuronal cells from oxygen glucose deprivation/re-oxygenation-induced oxidative injury and cell death. Aging (Albany NY). 2021 Feb 17;13(5):6712-6723. 4. Hensley K, et al. CPI-1189 inhibits interleukin 1beta-induced p38-mitogen-activated protein kinase phosphorylation: an explanation for its neuroprotective properties? Neurosci Lett. 2000 Mar 10;281(2-3):179-82. 5. Bjugstad KB, et al. Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia. Brain Res. 1998 Jun 8;795(1-2):349-57. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
4.268 ml |
21.341 ml |
42.682 ml |
| 5 mM |
0.854 ml |
4.268 ml |
8.536 ml |
| 10 mM |
0.427 ml |
2.134 ml |
4.268 ml |
| 50 mM |
0.085 ml |
0.427 ml |
0.854 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |